Medifast (MED) Cash from Operations (2010 - 2026)

Medifast (MED) has 17 years of Cash from Operations data on file, last reported at 260000.0 in Q1 2026.

• For the quarter ending Q1 2026, Cash from Operations fell 92.37% year-over-year to 260000.0; the trailing twelve-month figure through Mar 2026 stood at 3717000.0 (down 81.96% YoY), and the FY2025 full-year result was 6863000.0, down 71.96% from the prior year.
• Cash from Operations for Q1 2026 stood at 260000.0, up from 5278000.0 in the prior quarter.
• Across five years, Cash from Operations topped out at 64059000.0 in Q1 2023 and bottomed at 5278000.0 in Q4 2025.
• The 5-year median for Cash from Operations is 12113000.0 (2025), against an average of 21989764.71.
• The widest annual swing landed in 2022, when Cash from Operations surged 793.65%; it then plunged 147.02% in 2024.
• A 5-year view of Cash from Operations shows it stood at 51739000.0 in 2022, then sank by 79.66% to 10522000.0 in 2023, then sank by 147.02% to 4947000.0 in 2024, then fell by 6.69% to 5278000.0 in 2025, then surged by 104.93% to 260000.0 in 2026.
• The last three Cash from Operations figures came in at 260000.0 (Q1 2026), 5278000.0 (Q4 2025), and 12113000.0 (Q3 2025), per Business Quant data.

Peer Comparison